Related Experiment Video
Updated: Jun 13, 2026

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
NKX3.1 activates cellular response to DNA damage
1Departments of Medicine and Pathology, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York 10032, USA.
Abstract:
The prostate-specific tumor suppressor homeodomain protein NKX3.1 is inactivated by a variety of mechanisms in the earliest phases of prostate carcinogenesis and in premalignant regions of the prostate gland. The mechanisms by which NKX3.1 exercises tumor suppression have not been well elucidated. Here, we show that NKX3.1 affects DNA damage response and cell survival after DNA damage. NKX3.1 expression in PC-3 prostate cancer cells enhances colony formation after DNA damage but has minimal effect on apoptosis. NKX3.1 also diminishes and regulates total cellular accumulation of gammaH2AX. Endogenous NKX3.1 in LNCaP cells localizes to sites of DNA damage where it affects the recruitment of phosphorylated ATM and the phosphorylation of H2AX. Knockdown of NKX3.1 in LNCaP cells attenuates the acute responses of both ATM and H2AX phosphorylation to DNA damage and their subnuclear localization to DNA damage sites. NKX3.1 expression enhances activation of ATM as assayed by autophosphorylation at serine 1981 and activation of ATR as assayed by phosphorylation of CHK1. An inherited mutation of NKX3.1 that predisposes to early prostate cancer and attenuates in vitro DNA binding was devoid of the ability to activate ATM and to colocalize with gammaH2AX at foci of DNA damage. These data show a novel mechanism by which a homeoprotein can affect DNA damage repair and act as a tumor suppressor.
Insights
The prostate tumor suppressor NKX3.1 influences DNA damage response and cell survival. It regulates DNA repair proteins like ATM and H2AX, acting as a novel tumor suppressor mechanism.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Prostate-specific tumor suppressor homeodomain protein NKX3.1 is frequently inactivated during early prostate carcinogenesis.
- The precise mechanisms underlying NKX3.1's tumor suppressor functions remain incompletely understood.
Purpose of the Study:
- To elucidate the role of NKX3.1 in DNA damage response and cell survival pathways.
- To investigate how NKX3.1 interacts with key DNA damage response proteins.
Main Methods:
- Assessing NKX3.1's effect on colony formation and apoptosis post-DNA damage in prostate cancer cell lines (PC-3, LNCaP).
- Analyzing NKX3.1's impact on the accumulation and localization of gammaH2AX.
- Investigating NKX3.1's role in the recruitment and activation of ATM and ATR signaling pathways.
- Evaluating a specific NKX3.1 mutation linked to early prostate cancer.
Main Results:
- NKX3.1 expression enhances colony formation but minimally affects apoptosis after DNA damage.
- NKX3.1 regulates gammaH2AX accumulation and localizes to DNA damage sites, influencing ATM and H2AX phosphorylation.
- NKX3.1 knockdown attenuates ATM and H2AX responses to DNA damage.
- NKX3.1 enhances ATM and ATR activation; a cancer-predisposing mutation impairs these functions.
Conclusions:
- NKX3.1 plays a novel role in DNA damage response and repair.
- NKX3.1's interaction with ATM and H2AX is crucial for its tumor suppressor activity.
- Dysregulation of NKX3.1's DNA damage response function contributes to prostate carcinogenesis.
Related Concept Videos
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Nucleotide Excision Repair
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

